Palvella Therapeutics, Inc. - Feb 5, 2025 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
Chief Operating Officer
Signature
By: /s/ Kathleen A. McGowan For: Kathleen Goin
Stock symbol
PVLA
Transactions as of
Feb 5, 2025
Transactions value $
$0
Form type
4
Date filed
2/7/2025, 04:29 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVLA Incentive Stock Option (right to buy) Award $0 +5.37K $0.00 5.37K Feb 5, 2025 Common Stock 5.37K $14.76 Direct F1
transaction PVLA Non-Qualified Stock Option (right to buy) Award $0 +124K $0.00 124K Feb 5, 2025 Common Stock 124K $14.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in equal monthly tranches over 48 months